Literature DB >> 3859018

Successful treatment of gram-negative bacillary meningitis with imipenem/cilastatin.

K Rodriguez, G M Dickinson, R L Greenman.   

Abstract

A patient with meningitis caused by a strain of Actinetobacter anitratus that was resistant to all commercially available antibiotics was treated with imipenem/cilastatin administered intravenously in a dose of 1 gm of imipenem every six hours. The minimal inhibitory concentration of imipenem against the isolate was less than or equal to 0.04 micrograms/ml. The patient tolerated the drug well and was cured after 12 days of therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3859018     DOI: 10.1097/00007611-198506000-00028

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

1.  Clinical and bacteriological features of relapsing shunt-associated meningitis due to Acinetobacter baumannii.

Authors:  H Seifert; W Richter; G Pulverer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

Review 2.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

3.  Therapy of experimental meningitis due to Salmonella enteritidis.

Authors:  J P Bryan; W M Scheld
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

Review 4.  Safety of imipenem/cilastatin in neurocritical care patients.

Authors:  Jason Hoffman; Jason Trimble; Gretchen M Brophy
Journal:  Neurocrit Care       Date:  2008-12-31       Impact factor: 3.210

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.